Dyne Therapeutics, Inc.
Nasdaq: DYN
- Raised $116 million (2020)
- 4 clinical trials, 4 active
- Founded 2017
Life science companies
Explore 34,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Enliven Therapeutics, Inc.
Nasdaq: ELVN
- Raised $90 million (2024)
- 4 clinical trials, 4 active
- Founded 2016
Nuvation Bio Inc.
NYSE: NUVB
- Raised $275 million (2020)
- 19 clinical trials, 9 active
- Founded 2018
Quoin Pharmaceuticals Ltd.
Nasdaq: QNRX
- Raised $105 million (2025)
- 4 clinical trials, 4 active
- Founded 2018
Rein Therapeutics, Inc.
Nasdaq: RNTX
- Raised $18 million (2023)
- 9 clinical trials, 1 active
Taysha Gene Therapies, Inc.
Nasdaq: TSHA
- Raised $150 million (2023)
- 4 clinical trials, 3 active
- Founded 2019
Personal Genome Diagnostics Inc.
- Raised $98 million (2021)
- FDA-cleared or approved devices
- Research grants: $1.2 million
- Founded 2015
Alaunos Therapeutics, Inc.
Nasdaq: TCRT
- Raised $20 million (2019)
- 37 clinical trials
C2N Diagnostics, LLC
- Raised $10 million (2025)
- 4 clinical trials
- Research grants: $5.1 million
Pacific Diabetes Technologies, Inc.
- Raised $3.4 million (2025)
- 2 clinical trials
- Research grants: $4.3 million
- Founded 2021
Aldeyra Therapeutics, Inc.
Nasdaq: ALDX
- Raised $10 million (2019)
- 35 clinical trials, 1 active
Atsena Therapeutics, Inc.
- Raised $90 million (2025)
- 2 clinical trials, 2 active
- Research grants: $2.5 million
- Founded 2019
Grace Therapeutics, Inc.
Nasdaq: GRCE
- Raised $15 million (2025)
- 8 clinical trials, 1 active
Intelligent Hearing Systems Corp
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $16 million
Latigo Biotherapeutics, Inc.
Nasdaq: LTGO
- Raised $50 million (2025)
- 8 clinical trials, 1 active
Praxis Precision Medicines, Inc.
Nasdaq: PRAX
- Raised $10 million (2019)
- 17 clinical trials, 8 active
- Founded 2015
Renovion, Inc.
- Raised $15 million (2023)
- 2 clinical trials, 1 active
- Research grants: $3.6 million
- Founded 2013
Scion Neurostim, Inc.
- Raised $10 million (2023)
- 11 clinical trials, 1 active
- Research grants: $2 million
- Founded 2021
Theriva Biologics, Inc.
NYSE: TOVX
- Raised $13 million (2025)
- 8 clinical trials, 1 active
Capsulomics, Inc.
- Raised $2.4 million (2025)
- 1 clinical trial
- Research grants: $6.8 million
- Founded 2018
Showing 540 of 34,266 companies
Load morePublished company profiles only; counts update daily. Data licences